MHC class I and II deficiencies

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• MHC class I and II deficiencies are rare, autosomal recessive primary immunodeficiencies.
• MHC class II deficiency exemplifies a gene regulation disorder, caused by defects in regulatory factors, not the MHC genes themselves.

Purpose of the Study:

• To review the clinical, genetic, and molecular characteristics of MHC class I and II deficiencies.
• To discuss current and potential therapeutic options for these rare conditions.

Main Methods:

• Review of existing literature on MHC class I and II deficiencies.
• Analysis of genetic defects in transacting regulatory factors controlling MHC class II gene expression.

Main Results:

• MHC class II deficiency involves mutations in regulatory factors like the class II transactivator and RFX subunits (RFXANK, RFX5, RFXAP).
• MHC class I deficiency is extremely rare, with fewer than 30 reported cases globally.
• The study of these deficiencies has illuminated the molecular mechanisms of MHC regulation.

Conclusions:

• Defects in MHC class I and II impact immune function and are linked to specific genetic mutations.
• Further research into MHC regulation is crucial for understanding and treating these rare immunodeficiencies.